Literature DB >> 26203123

Growth attenuation therapy: practice and perspectives of paediatric endocrinologists.

Allison J Pollock1, Norman Fost1, David B Allen1.   

Abstract

Entities:  

Keywords:  Endocrinology; Ethics; General Paediatrics; Growth; Neurodisability

Mesh：

Year:  2015        PMID： 26203123      PMCID： PMC4762252          DOI： 10.1136/archdischild-2015-309130

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  The current use of estrogens for growth-suppressant therapy in adolescent girls.

Authors:  Neal D Barnard; Anthony R Scialli; Suzanne Bobela
Journal:  J Pediatr Adolesc Gynecol       Date:  2002-02       Impact factor: 1.814

2.  Estrogen use in children and adolescents: a survey.

Authors:  F A Conte; M M Grumbach
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

3.  Navigating growth attenuation in children with profound disabilities. Children's interests, family decision-making, and community concerns.

Authors:  Benjamin S Wilfond; Paul Steven Miller; Carolyn Korfiatis; Douglas S Diekema; Denise M Dudzinski; Sara Goering
Journal:  Hastings Cent Rep       Date:  2010 Nov-Dec       Impact factor: 2.683
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.